semaglutide vs bariatric surgery The Potential of Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Surgery—a Retrospective Analysis | Obesity Once-weekly semaglutide administered after laparoscopic
Description
The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight
In certain cases, binge eating disorder occurs along with other mental health conditions, such as anxiety disorders, depression, post-traumatic stress disorder (PTSD), or substance abuse
What happens when you get the water volume wrong Mistakes happen
Given that there are now GLP-1 pills, I'm wondering if the adoption curve will change
